Takara Bio Granted Mfg. License From Sweden’s Medical Authority

Allows for clinical-grade human embryonic stem cell line derivation and banking

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The Medical Products Agency (MPA), the Swedish national authority responsible for regulation and surveillance of the development, manufacturing and marketing of drug and other medical products, recently granted Takara Bio a manufacturing license for derivation and banking of human embryonic stem (hES) cells to be produced under GMP conditions at the state-of-the-art laboratory located in Göteborg, Sweden, within Takara Bio Europe’s facility. Since October 2014, Takara Bio has been offer...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters